Celltrion Healthcare Ranks High in Searches... Stock Price Up 6.69%
As of 1:30 PM on the 21st, Celltrion Healthcare is trading at 173,800 KRW, up 6.69% from the previous day. This marks a 74.15% increase compared to November 24. Celltrion Healthcare is known as the exclusive distributor of Celltrion's biosimilars.
Today, foreigners have a net purchase of 422,174 shares of Celltrion Healthcare, and institutions have a net purchase of 5,000 shares, according to provisional data. Over the past five days, individual investors have net sold 489,616 shares, while foreigners and institutions have net bought 525,829 shares and 1,456 shares, respectively.
Hot Picks Today
Cerebras Soars 70% on IPO Debut: Is Nvidia's Reign Ending as a New AI Semiconductor Power Emerges?
- [Breaking] Samsung Electronics Executives: "We Will Participate Unconditionally... We Urge the Union to Join the Talks"
- "Gave in to the Momentary Temptation": Japanese Police Official Dismissed After Stealing 100 Million Won Next to Body
- "Mom, Isn't It Comfortable Living With Me?"... 'Unexpected Result' Shows Increased Drinking Out of Frustration
- "After Vowing to Become No. 1 Globally, Sudden Policy Brake Puts Companies’ Massive Investments at Risk"
※ Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an article automation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
